SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-053988
Filing Date
2021-11-03
Accepted
2021-11-03 16:31:39
Documents
74
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q adpt-10q_20210930.htm   iXBRL 10-Q 2823117
2 EX-31.1 adpt-ex311_54.htm EX-31.1 27598
3 EX-31.2 adpt-ex312_53.htm EX-31.2 28823
4 EX-32.1 adpt-ex321_52.htm EX-32.1 12147
5 EX-32.2 adpt-ex322_51.htm EX-32.2 13408
  Complete submission text file 0001564590-21-053988.txt   9574049

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA adpt-20210930.xsd EX-101.SCH 56679
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adpt-20210930_cal.xml EX-101.CAL 55967
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adpt-20210930_def.xml EX-101.DEF 201834
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE adpt-20210930_lab.xml EX-101.LAB 439487
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adpt-20210930_pre.xml EX-101.PRE 355549
11 EXTRACTED XBRL INSTANCE DOCUMENT adpt-10q_20210930_htm.xml XML 1856786
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38957 | Film No.: 211375963
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences